PEG-ASP+CHOP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PEG-ASP+CHOP, covering 2020-01-28 to 2020-01-28. Get the full timeline:
Most recent: Clinical Trial Update: PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage [Phase 2]